KAT2A and prostate cancer: Intriguingly, SREBF1 has been report to interact with the epigenetic marks in cancer development, recruiting KAT2A/GCN5 to deposit the epigenetic mark H2A-K130ac on SREBF1, thereby reigniting lipogenesis and steroidogenesis in prostate cancer [24].